Rheological and in vitro release measurements of manufactured acyclovir 5% creams: confirming sensitivity of the in vitro release

References

• Ault JM, Riley CM, Meltzer NM, Lunte CE. 1994. Dermal microdialysis sampling in vivo. Pharm Res. 11(11):1631–1639.
   PubMed Web of Science ®Google Scholar
• Cardot JM, Garrait G, Beyssac E. 2015. Use of IVIVC to optimize generic development. Dissolution Technol. 22(2):44–48.
   Web of Science ®Google Scholar
• Caron D, Queille-Roussel C, Shah VP, Schaefer H. 1990. The correlation between the drug penetration, and vasoconstriction of hydrocortisone creams in humans. J Am Acad Dermatol. 23(3):458–462.
   PubMed Web of Science ®Google Scholar
• [EMA] European Medicine Agency. 2018. Committee for Medicinal Products for Human use (CHMP). Draft guideline on quality and equivalence of topical products.
   Google Scholar
• Holmgaard R, Benfeldt E, Bangsgaard N, Sorensen JA, Brosen K, Nielsen F, Nielsen JB. 2012. Probe depth matters in dermal microdialysis sampling of benzoic acid after topical application: an ex vivo study in human skin. Skin Pharmacol Physiol. 25(1):9–16.
   PubMed Web of Science ®Google Scholar
• Krishnaiah YS, Xu X, Rahman Z, Yang Y, Katragadda U, Lionberger R, Peters JR, Uhl K, Khan MA. 2014. Development of performance matrix for generic product equivalence of acyclovir topical creams. Int J Pharm. 475(1–2):110–122.
   PubMedGoogle Scholar
• Mangas-Sanjuán V, Pleguezuelos-Villa M, Merino-Sanjuán M, Hernández MJ, Nácher A, García-Arieta A, Peris D, Hidalgo I, Soler L, Sallan M, et al. 2019. Assessment of the inter-batch variability of microstructure parameters in topical semisolids and impact on the demonstration of equivalence. Pharmaceutics. 11(10):503.
   Web of Science ®Google Scholar
• Miron DS, Rădulescu FS, Benfeldt E, Shah VP, Voicu VA. 2014. In vitro and in vivo evaluation of three metronidazole topical products. Pharm Dev Technol. 19(2):194–199.
   PubMed Web of Science ®Google Scholar
• [NIHS] National Institute of Health Sciences (Japan). 2003. Guideline for Bioequivalence Studies of Generic Products for Topical Use.
   Google Scholar
• Patel N, Martins F, Jamei M, Ghosh P, Raney SG, Zhang X, Tsakalozou E, Ni Z, Polak S. 2017. Integration of physicochemical product characteristics within a mechanistic dermal PBPK model to support virtual bioequivalence evaluation of topical drug products: A case study with acyclovir topical creams. Poster presented at: 2017 American Association of Pharmaceutical Scientists’ (AAPS) Annual Meeting and Exposition; November 12–15, San Diego, CA.
   Google Scholar
• Pershing LK, Bakhtian S, Poncelet CE, Corlett JL, Shah VP. 2002. Comparison of skin stripping, in vitro release, and skin blanching response methods to measure dose response and similarity of triamcinolone acetonide cream strengths from two manufactured sources. J Pharm Sci. 91(5):1312–1323.
   PubMed Web of Science ®Google Scholar
• Polli JE. 2008. In vitro studies are sometimes better than conventional human pharmacokinetic in vivo studies in assessing bioequivalence of immediate-release solid oral dosage forms. Aaps J. 10(2):289–299.
   PubMed Web of Science ®Google Scholar
• Raghavan L, Brown M, Michniak-Kohn B, Ng S, Sammeta S. 2019. In vitro release tests as a critical quality attribute in topical product development. In: Langley N, Michniak-Kohn B, Osborne DW, editors. The role of microstructure in topical drug product development. AAPS Advances in the Pharmaceutical Sciences Series. New York (NY): AAPS Springer; p. 47–87.
   Google Scholar
• Rowe RC, Sheskey PJ, Quinn ME. 2009. Handbook of pharmaceutical excipients. 6th ed. London (UK): Pharmaceutical Press.
   Google Scholar
• Rădulescu FS. 2019. In Vitro Release and Q3 Measurements for Semisolid Drug Products. Presentation included in Track #1 Novel approaches to improve treatment outcome and patient safety. Presentation at: The 4th PQRI/FDA Conference on Advancing Product Quality: Patient-Centric Product Design, Drug Development, and Manufacturing, April 9–11, Rockville, MD.
   Google Scholar
• Shah VP. 2005. IV-IVC for topically applied preparations – a critical evaluation. Eur J Pharm Biopharm. 60(2):309–314.
   PubMed Web of Science ®Google Scholar
• Shah VP, Elkins J, Hanus J, Noorizadeh C, Skelly JP. 1991. In vitro release of hydrocortisone from topical preparations and automated procedure. Pharm Res. 8(1):55–59.
   PubMed Web of Science ®Google Scholar
• Shah VP, Elkins J, Lam SY, Skelly JP. 1989. Determination of in vitro release from hydrocortisone creams. In J Pharm. 53(1):53–59.
   Google Scholar
• Shah VP, Elkins J, Shaw S, Hanson R. 2003. In vitro release: comparative evaluation of vertical diffusion cell system and automated procedure. Pharm Dev Technol. 8(1):97–102.
   PubMed Web of Science ®Google Scholar
• Shah VP, Elkins J, Skelly JP. 1992. Relationship between in vivo skin blanching and in vitro release rate for betamethasone valerate creams. J Pharm Sci. 81(1):104–106.
   PubMed Web of Science ®Google Scholar
• Shah VP, Rădulescu FŞ, Miron DS, Yacobi A. 2016. Commonality between BCS and TCS. Int J Pharm. 509(1–2):35–40.
   PubMedGoogle Scholar
• Shah VP, Yacobi A, Rădulescu FŞ, Miron DS, Lane ME. 2015. A science based approach to topical drug classification system (TCS). Int J Pharm. 491(1–2):21–25.
   PubMedGoogle Scholar
• Shen J, Burgess DJ. 2015. In vitro-in vivo correlation for complex non-oral drug products: where do we stand? J Control Release. 219:644–651.
   PubMed Web of Science ®Google Scholar
• Trottet L, Owen H, Holme P, Heylings J, Collin IP, Breen AP, Siyad MN, Nandra RS, Davis AF. 2005. Are all aciclovir cream formulations bioequivalent? Int J Pharm. 304(1–2):63–71.
   PubMedGoogle Scholar
• [US-FDA] U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). 1997. Guidance for industry. Nonsterile semisolid dosage forms. Scale-up and post approval changes. Chemistry, manufacturing and controls. In vitro release testing and in vivo bioequivalence documentation.
   Google Scholar
• [US-FDA] U.S. Department of Health and Human Services, Food and Drug Administration, Office of Generic Drugs. 2017. Draft guidance on Silver Sulfadiazine Cream.
   Google Scholar
• [US-FDA] U.S. Department of Health and Human Services, Food and Drug Administration, Office of Generic Drugs. 2011. Draft guidance on Ciclopirox Topical Solution.
   Google Scholar
• [USP] United States Pharmacopoeia 42 – National Formulary 37, supplement 2. 2019. Specific monograph: Cetostearyl alcohol. Rockville (MD): United States Pharmacopeial Convention.
   Google Scholar